InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Rory B Riggs, Director, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 29 open-market SEC Form 4 transactions: 2 purchases worth $5.5M and 27 sales worth $122.5M, reported from Sep 28, 21 to Jun 24, 24. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 24, 24 | ITCIIntra-Cellular Therapies, Inc. | SELL | 4.5K | $75.57 | $337K |
| Jan 4, 24 | RPRXRoyalty Pharma plc | SELL | 35.7K | $27.55 | $984K |
| Jan 3, 24 | RPRXRoyalty Pharma plc | SELL | 199.1K | $27.79 | $5.5M |
| Jan 2, 24 | RPRXRoyalty Pharma plc | SELL | 235.2K | $28.52 | $6.7M |
| Dec 12, 23 | CBUSCibus, Inc. | BUY | 517.1K | $10.58 | $5.5M |
| Jun 1, 23 | CBUSCibus, Inc. | BUY | 1.0K | $31.50 | $32K |
| May 22, 23 | RPRXRoyalty Pharma plc | SELL | 1.75M | $32.82 | $57.4M |
| Mar 30, 23 | RPRXRoyalty Pharma plc | SELL | 130.0K | $36.26 | $4.7M |
| Mar 29, 23 | RPRXRoyalty Pharma plc | SELL | 9.9K | $36.95 | $367K |
| Dec 9, 22 | RPRXRoyalty Pharma plc | SELL | 20.0K | $42.07 | $841K |
| Nov 17, 22 | RPRXRoyalty Pharma plc | SELL | 120.0K | $42.33 | $5.1M |
| Sep 15, 22 | RPRXRoyalty Pharma plc | SELL | 52.0K | $42.21 | $2.2M |
| Sep 14, 22 | RPRXRoyalty Pharma plc | SELL | 48.0K | $42.41 | $2.0M |
| Aug 9, 22 | RPRXRoyalty Pharma plc | SELL | 45.0K | $43.73 | $2.0M |
| Jun 29, 22 | RPRXRoyalty Pharma plc | SELL | 30.0K | $42.17 | $1.3M |
| May 20, 22 | RPRXRoyalty Pharma plc | SELL | 123.7K | $39.28 | $4.9M |
| May 19, 22 | RPRXRoyalty Pharma plc | SELL | 26.3K | $40.09 | $1.1M |
| Mar 29, 22 | RPRXRoyalty Pharma plc | SELL | 60.0K | $38.59 | $2.3M |
| Mar 21, 22 | RPRXRoyalty Pharma plc | SELL | 25.5K | $39.05 | $998K |
| Mar 18, 22 | RPRXRoyalty Pharma plc | SELL | 56.2K | $39.77 | $2.2M |
| Mar 18, 22 | ITCIIntra-Cellular Therapies, Inc. | SELL | 15.7K | $61.35 | $965K |
| Mar 17, 22 | ITCIIntra-Cellular Therapies, Inc. | SELL | 114.9K | $60.41 | $6.9M |
| Mar 16, 22 | ITCIIntra-Cellular Therapies, Inc. | SELL | 43.8K | $59.53 | $2.6M |
| Dec 29, 21 | RPRXRoyalty Pharma plc | SELL | 75.0K | $40.00 | $3.0M |
| Dec 28, 21 | RPRXRoyalty Pharma plc | SELL | 47.6K | $40.21 | $1.9M |
| Nov 17, 21 | RPRXRoyalty Pharma plc | SELL | 69.2K | $42.39 | $2.9M |
| Nov 16, 21 | RPRXRoyalty Pharma plc | SELL | 12.6K | $42.01 | $528K |
| Sep 29, 21 | RPRXRoyalty Pharma plc | SELL | 34.6K | $36.67 | $1.3M |
| Sep 28, 21 | RPRXRoyalty Pharma plc | SELL | 40.0K | $36.75 | $1.5M |